Literature DB >> 12072677

A pilot study of coupled plasma filtration with adsorption in septic shock.

Claudio Ronco1, Alessandra Brendolan, Gerhard Lonnemann, Rinaldo Bellomo, Pasquale Piccinni, Antonio Digito, Maurizio Dan, Marco Irone, Giuseppe La Greca, Paola Inguaggiato, Umberto Maggiore, Concetta De Nitti, Mary Lou Wratten, Zaccaria Ricci, Ciro Tetta.   

Abstract

OBJECTIVE: To test the hypothesis that nonselective plasma adsorption by a hydrophobic resin (coupled plasmafiltration and adsorption) could improve hemodynamics and restore leukocyte responsiveness in patients with septic shock.
DESIGN: Prospective, pilot, crossover clinical trial.
SETTING: General intensive care unit in a teaching hospital.
SUBJECTS: Ten patients with hyperdynamic septic shock.
INTERVENTIONS: Patients were randomly allocated to 10 hrs of either coupled plasma filtration adsorption plus hemodialysis (treatment A) or continuous venovenous hemodiafiltration (treatment B) in random order. We measured the change in mean arterial pressure, norepinephrine requirements, and leukocyte tumor necrosis factor-alpha (TNF-alpha) production (both spontaneous and lipopolysaccharide-stimulated) after 10 hrs of each treatment. We also tested TNF-alpha production from normal human adherent monocytes incubated with patients' plasma obtained before and after the resin, both with or without incubation with an anti-interleukin-10 monoclonal antibody.
RESULTS: Mean arterial pressure increased after 10 hr by 11.8 mm Hg with treatment A and by 5.5 mm Hg with treatment B (p =.001). There was an average decrease of norepinephrine requirement of 0.08 microg/kg/min with treatment A and 0.0049 microg/kg/min with treatment B (p =.003). All patients but one survived. Spontaneous and lipopolysaccharide-induced TNF-alpha production from patients' whole blood increased over time with treatment A. This increase was more marked in blood drawn after the device (plasmafiltrate-sorbent plus hemodialyzer) (p =.009). Preresin plasma suppressed lipopolysaccharide-stimulated production of TNF-alpha by 1 x 10(6)cultured adherent monocytes from healthy donors. This suppressive effect was significantly reduced after passage of plasma through the resin (p =.019) and after incubation with anti-interleukin-10 monoclonal antibodies (p =.028).
CONCLUSIONS: In patients with septic shock, coupled plasmafiltration-adsorption combined with hemodialysis was associated with improved hemodynamics compared with continuous venovenous hemodiafiltration. This result might be related to its ability to restore leukocyte responsiveness to lipopolysaccharide. These findings suggest a potential role for blood purification in the treatment of septic shock.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072677     DOI: 10.1097/00003246-200206000-00015

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  43 in total

Review 1.  [Continuous dialysis and hemofiltration. More than a kidney replacement method?].

Authors:  M Girndt; H Köhler
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

2.  Early isovolaemic haemofiltration in oliguric patients with septic shock.

Authors:  Pasquale Piccinni; Maurizio Dan; Stefano Barbacini; Rizzieri Carraro; Emanuela Lieta; Silvio Marafon; Nereo Zamperetti; Alessandra Brendolan; Vincenzo D'Intini; Ciro Tetta; Rinaldo Bellomo; Claudio Ronco
Journal:  Intensive Care Med       Date:  2005-11-18       Impact factor: 17.440

Review 3.  Blood purification and mortality in sepsis: a meta-analysis of randomized trials.

Authors:  Feihu Zhou; Zhiyong Peng; Raghavan Murugan; John A Kellum
Journal:  Crit Care Med       Date:  2013-09       Impact factor: 7.598

4.  Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.

Authors:  Zhi-Yong Peng; Hong-Zhi Wang; Melinda J Carter; Morgan V Dileo; Jeffery V Bishop; Fei-Hu Zhou; Xiao-Yan Wen; Thomas Rimmelé; Kai Singbartl; William J Federspiel; Gilles Clermont; John A Kellum
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

Review 5.  [Adsorption therapy in sepsis].

Authors:  D Hasper; J C Schefold; A Jörres
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-09-24       Impact factor: 0.840

6.  Management of acute renal dysfunction in sepsis.

Authors:  Federico Nalesso; Zaccaria Ricci; Claudio Ronco
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

7.  Coupled plasma filtration adsorption.

Authors:  Rinaldo Bellomo; Ciro Tetta; Claudio Ronco
Journal:  Intensive Care Med       Date:  2003-06-26       Impact factor: 17.440

8.  A rare association of emphysematous pyelonephritis with unrecognized diabetes and polycystic kidney.

Authors:  A M Azzini; P Sette; G Castellano; R M Dorizzi
Journal:  Indian J Nephrol       Date:  2009-01

9.  Sepsis-induced acute kidney injury.

Authors:  Arghya Majumdar
Journal:  Indian J Crit Care Med       Date:  2010-01

10.  Protective effect of resin adsorption on septic plasma-induced tubular injury.

Authors:  Vincenzo Cantaluppi; Viktoria Weber; Carola Lauritano; Federico Figliolini; Silvia Beltramo; Luigi Biancone; Massimo De Cal; Dinna Cruz; Claudio Ronco; Giuseppe Paolo Segoloni; Ciro Tetta; Giovanni Camussi
Journal:  Crit Care       Date:  2010-01-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.